The Gross Margin of Tandem Diabetes Care, Inc. (TNDM) is
53.81%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date |
Value |
| 2025-12-31 |
53.81%
|
| 2024-12-31 |
52.07%
|
| 2023-12-31 |
49.17%
|
| 2022-12-31 |
51.55%
|
| 2021-12-31 |
53.53%
|
| 2020-12-31 |
52.23%
|
| 2019-12-31 |
53.60%
|
| 2018-12-31 |
48.89%
|
| 2017-12-31 |
40.99%
|
| 2016-12-31 |
27.91%
|
| Ticker |
Name |
Value |
|
INMD
|
InMode Ltd.
|
78.54%
|
|
NVRO
|
Nevro LLC
|
66.37%
|
|
CMD
|
Cantel Medical Corp
|
45.53%
|
|
OM
|
Outset Medical, Inc.
|
39.13%
|
|
RMD
|
ResMed Inc.
|
61.06%
|
|
CNMD
|
Conmed Corp
|
53.87%
|
|
BDX
|
Becton Dickinson and Co
|
47.36%
|
|
BSX
|
Boston Scientific Corporation
|
69.01%
|
|
IART
|
Integra LifeSciences Holdings Corporation
|
56.62%
|
|
NNOX
|
Nano-X Imaging Ltd
|
-98.21%
|
|
ATRC
|
AtriCure, Inc.
|
74.98%
|
|
CRY
|
Artivion Inc
|
6625.83%
|
|
CSII
|
Cardiovascular Systems Inc
|
73.14%
|
|
EAR
|
Eargo Inc
|
38.28%
|
|
EW
|
Edwards Lifesciences Corporation
|
78.01%
|
|
HSKA
|
Heska Corp
|
43.20%
|
|
ISRG
|
Intuitive Surgical, Inc.
|
66.00%
|
|
MLAB
|
Mesa Laboratories, Inc.
|
63.53%
|
|
AXNX
|
Axonics Inc
|
74.94%
|
|
SYK
|
Stryker Corporation
|
64.57%
|
|
IDXX
|
IDEXX Laboratories, Inc.
|
61.80%
|
|
LIVN
|
LivaNova PLC
|
67.71%
|
|
NARI
|
Inari Medical Inc
|
88.03%
|
|
PEN
|
Penumbra, Inc.
|
67.14%
|
|
GNMK
|
Genmark Diagnostics Inc
|
39.61%
|
|
TCMD
|
Tactile Systems Technology, Inc.
|
50.79%
|
|
DHR
|
Danaher Corporation
|
59.23%
|
|
ATEC
|
Alphatec Holdings, Inc.
|
69.60%
|
|
DXCM
|
Dexcom Inc
|
62.09%
|
|
GKOS
|
Glaukos Corporation
|
77.97%
|
|
ITGR
|
Integer Holdings Corp
|
27.39%
|
|
NUVA
|
NuVasive Inc
|
72.00%
|
|
OFIX
|
Orthofix Medical Inc.
|
68.83%
|
|
SWAV
|
Shockwave Medical Inc
|
86.94%
|
|
ABT
|
Abbott Laboratories
|
56.66%
|
|
INGN
|
Inogen, Inc.
|
44.24%
|
|
NTUS
|
Natus Medical Inc
|
57.70%
|
|
GMED
|
Globus Medical, Inc.
|
67.41%
|